Intended for healthcare professionals

  1. Research
  2. Comparative benefits...
  3. Comparative benefits and harms of second generation antidepressants and cognitive behavioral therapies in initial treatment of major depressive disorder: systematic review and meta-analysis
CCBYNC Open access
Research

Comparative benefits and harms of second generation antidepressants and cognitive behavioral therapies in initial treatment of major depressive disorder: systematic review and meta-analysis

BMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h6019 (Published 08 December 2015) Cite this as: BMJ 2015;351:h6019

Data supplement

Related articles

EditorialCognitive behavioural therapy or antidepressants for acute depression?

See more

Cited by...

  • Morita Therapy for depression (Morita Trial): an embedded qualitative study of acceptability
  • Is there a genuine placebo effect in acute depression treatments? A reassessment of regression to the mean and spontaneous remission
  • Depression in primary care: part 2--management
  • Morita Therapy for depression (Morita Trial): a pilot randomised controlled trial
  • Frequency of reporting on patient and public involvement (PPI) in research studies published in a general medical journal: a descriptive study
  • Pharmacological and non-pharmacological treatments for major depressive disorder: review of systematic reviews
  • Cost and outcome of behavioural activation versus cognitive behavioural therapy for depression (COBRA): a qualitative process evaluation
  • Initial severity of depression and efficacy of cognitive-behavioural therapy: individual-participant data meta-analysis of pill-placebo-controlled trials
  • Non-pharmacological treatment of depression: a systematic review and evidence map
  • Treating seasonal affective disorder with cognitive behavioural therapy is comparable to light therapy
  • The problem of accessing psychotherapies for depression in the UK
  • Cognitive behavioural therapy or antidepressants for acute depression?
Back to top